Tackling Noncommunicable Diseases in Africa: Caveat Lector

被引:9
|
作者
Mensah, George A. [1 ]
机构
[1] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA
关键词
Africa; chronic diseases; demographic changes; noncommunicable diseases; risk factors; urbanization; RHEUMATIC HEART-DISEASE; RISK-FACTORS; URBANIZATION; OBESITY; BURDEN;
D O I
10.1177/1090198116633454
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Noncommunicable disease (NCD), principally cardiovascular diseases, cancer, chronic lung disease, and diabetes, constitutes the major cause of death worldwide. Evidence of a continuing increase in the global burden of these diseases has generated recent urgent calls for global action to tackle and reduce related death and disability. Because the majority of NCD deaths occur in low- and middle-income countries, increased attention has been focused on this group of countries. However, in sub-Saharan Africa, where all countries are members of the low- and middle-income grouping, NCDs are not the leading causes of death or potential life years lost. Thus, strategies to tackle NCDs in sub-Saharan Africa are best conceived and executed in alignment with existing strategies for the prevention, treatment, and control of the actual leading causes of death in this region. This commentary addresses caveats to be considered as strategies are developed to tackle NCDs in sub-Saharan Africa as part of the global effort to prevent, treat, and control NCDs.
引用
收藏
页码:7S / 13S
页数:7
相关论文
共 50 条
  • [41] China engages Asia? Caveat lector - Reply
    Shambaugh, D
    [J]. INTERNATIONAL SECURITY, 2005, 30 (01) : 205 - 211
  • [42] Tackling the Rising Trends of Noncommunicable Diseases During Public Health Emergencies
    Shrivastava, Saurabh RamBihariLal
    Shrivastava, Prateek Saurabh
    Ramasamy, Jegadeesh
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2016, 7
  • [43] Chronicity and control: framing 'noncommunicable diseases' in Africa
    Whyte, Susan Reynolds
    [J]. ANTHROPOLOGY & MEDICINE, 2012, 19 (01) : 63 - 74
  • [44] Patient Registry Analyses: Seize the Data, but Caveat Lector
    Schechter, Michael S.
    [J]. JOURNAL OF PEDIATRICS, 2008, 153 (06): : 733 - 735
  • [45] Antioxidant therapy for muscular dystrophy: caveat lector! Reply
    Pinniger, Gavin J.
    Terrill, Jessica R.
    Grounds, Miranda D.
    Arthur, Peter G.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2018, 596 (04): : 739 - 739
  • [46] CAVEAT LECTOR - REVIEWING POPULAR SOCIAL-SCIENCE
    HIXSON, VS
    [J]. JOURNAL OF COMMUNICATION, 1981, 31 (02) : 168 - 177
  • [47] Evolution of transcription-regulating proteins: caveat lector!
    Arst, HN
    Holden, DW
    Caddick, MX
    [J]. GENE, 1997, 173 : S1 - S4
  • [48] Statistical reviewing policies of medical journals - Caveat lector?
    Goodman, SN
    Altman, DG
    George, SL
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 1998, 13 (11) : 753 - 756
  • [49] Caveat lector: D'Annunzio's autobiographical prestidigitation
    Woodhouse, JR
    [J]. MODERN LANGUAGE REVIEW, 1996, 91 : 610 - 618
  • [50] Gain in Popularity of Noninferiority Trial Design: Caveat Lector
    Vermeulen, Lee
    [J]. PHARMACOTHERAPY, 2011, 31 (09): : 831 - 832